Cargando…

Tumor necrosis factor α inhibition overcomes immunosuppressive M2b macrophage-induced bevacizumab resistance in triple-negative breast cancer

Bevacizumab in neoadjuvant therapy provides a new hope of improved survival for patients with triple-negative breast cancer (TNBC) by targeting vascular endothelial growth factor in combination with chemotherapy, but curative effect is limited by bevacizumab’s continuous use while mechanisms remain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yu, Ji, Xuemei, Kang, Nannan, Zhou, Junfei, Liang, Xue, Li, Jiaxin, Han, Tianzhen, Zhao, Chen, Yang, Tianwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678839/ https://www.ncbi.nlm.nih.gov/pubmed/33214550 http://dx.doi.org/10.1038/s41419-020-03161-x

Ejemplares similares

Endothelial-Specific Molecule 1 Inhibition Lessens Productive Angiogenesis and Tumor Metastasis to Overcome Bevacizumab Resistance
por: Kang, Nannan, et al.
Publicado: (2022)

Novel specific anti‐ESM1 antibodies overcome tumor bevacizumab resistance by suppressing angiogenesis and metastasis
por: Kang, Nannan, et al.
Publicado: (2023)

Understanding and overcoming the immunosuppressive effects of glioma induced immunosuppression
por: Moertel, Christopher, et al.
Publicado: (2013)

Tumour Necrosis Factor-α Gene Polymorphism Is Associated with Metastasis in Patients with Triple Negative Breast Cancer
por: Li, Hui-Hui, et al.
Publicado: (2015)

Research advances and new challenges in overcoming triple-negative breast cancer
por: Zong, Yu, et al.
Publicado: (2021)

Macrophage-Derived Adenosine Deaminase 2 Correlates with M2 Macrophage Phenotype in Triple Negative Breast Cancer
por: Kutryb-Zajac, Barbara, et al.
Publicado: (2021)

Role of SMC1 in Overcoming Drug Resistance in Triple Negative Breast Cancer
por: Yadav, Sushma, et al.
Publicado: (2013)

Overcoming the Challenges of Phytochemicals in Triple Negative Breast Cancer Therapy: The Path Forward
por: Alaouna, Mohammed, et al.
Publicado: (2023)

Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma
por: Rohila, Deepak, et al.
Publicado: (2023)

Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment
por: Sun, Bo, et al.
Publicado: (2020)

Overcoming the Immunosuppressive Tumor Microenvironment in Multiple Myeloma
por: Uckun, Fatih M.
Publicado: (2021)

Identification of Genes Associated with Prognosis and Immunotherapy Prediction in Triple-Negative Breast Cancer via M1/M2 Macrophage Ratio
por: Liu, Jianyu, et al.
Publicado: (2023)

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023)

Inhibition of glycolysis-driven immunosuppression with a nano-assembly enhances response to immune checkpoint blockade therapy in triple negative breast cancer
por: Ren, Xijiao, et al.
Publicado: (2023)

BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers
por: Blanchard, Zannel, et al.
Publicado: (2015)

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
por: Saatci, Ozge, et al.
Publicado: (2020)

Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
por: Lee, Joyce V., et al.
Publicado: (2022)

Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR-mutant lung cancer with HIF-1α/TGF-α expression
por: Nishii, Kazuya, et al.
Publicado: (2021)

Low-Dose Bevacizumab Is Effective in Radiation-Induced Necrosis
por: Alessandretti, Matheus, et al.
Publicado: (2013)

Adverse events of bevacizumab for triple negative breast cancer and HER-2 negative metastatic breast cancer: A meta-analysis
por: Xun, Xueqiong, et al.
Publicado: (2023)

Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma
por: Salaroglio, Iris Chiara, et al.
Publicado: (2014)

Understanding and Overcoming Immunosuppression Shaped by Cancer Stem Cells
por: Li, Linheng, et al.
Publicado: (2023)

High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs
por: Onagi, Hiroko, et al.
Publicado: (2022)

Anti-glucocorticoid-induced Tumor Necrosis Factor–Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal Effects
por: Schoenhals, Jonathan E., et al.
Publicado: (2018)

Tumor Necrosis Factor-α (TNFα) Stimulate Triple-Negative Breast Cancer Stem Cells to Promote Intratumoral Invasion and Neovasculogenesis in the Liver of a Xenograft Model
por: Narasimhan, Harini, et al.
Publicado: (2022)

Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation
por: Zhuang, Hongqing, et al.
Publicado: (2016)

Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues
por: Zhuang, Hongqing, et al.
Publicado: (2019)

Clinical Experience of Bevacizumab for Radiation Necrosis in Patients with Brain Metastasis
por: Park, Moowan, et al.
Publicado: (2020)

Triple-negative breast cancer influences a mixed M1/M2 macrophage phenotype associated with tumor aggressiveness
por: Pe, Kristine Cate S., et al.
Publicado: (2022)

Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients
por: Boucher, Yves, et al.
Publicado: (2021)

Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38
por: Gohr, Katharina, et al.
Publicado: (2017)

Macrophage Colony-stimulating Factor Mediates the Recruitment of Macrophages in Triple negative Breast Cancer
por: Lu, Xiaoqing, et al.
Publicado: (2019)

Injecting Immunosuppressive M2 Macrophages Alleviates the Symptoms of Periodontitis in Mice
por: Miao, Yibin, et al.
Publicado: (2020)

d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma
por: Han, Shulan, et al.
Publicado: (2023)

Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
por: Cazet, Aurélie S., et al.
Publicado: (2018)

Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51
por: Lee, Jung Ok, et al.
Publicado: (2019)

Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
por: Lee, Joyce V., et al.
Publicado: (2022)

Macrophage phenotype in sepsis immunosuppression
por: Theodorakis, E, et al.
Publicado: (2015)

Tumor-Associated Macrophages: Key Players in Triple-Negative Breast Cancer
por: Qiu, Xia, et al.
Publicado: (2022)

Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients
por: Wang, Yang, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8pk4ii6u9bi6imabanc9uimq7v